Deutsche Bank Ag\ Eloxx Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$1.22 - $2.0 $82,960 - $136,000	-68,000 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$1.35 - $3.36 $67,616 - $168,288	50,086 Added 279.59%	68,000 $135,000
Q1 2021 May 13, 2021	SELL	$3.02 - $4.54 $4,883 - $7,341	-1,617 Reduced 8.28%	17,914 $59,000
Q4 2020 Feb 16, 2021	BUY	$2.42 - $4.48 $11,770 - $21,790	4,864 Added 33.16%	19,531 $77,000
Q3 2020 Nov 12, 2020	BUY	$2.53 - $3.4 $3,268 - $4,392	1,292 Added 9.66%	14,667 $39,000
Q2 2020 Aug 13, 2020	BUY	$1.56 - $3.65 $7,633 - $17,859	4,893 Added 57.69%	13,375 $40,000
Q1 2020 May 14, 2020	SELL	$1.96 - $7.96 $1,007 - $4,091	-514 Reduced 5.71%	8,482 $16,000
Q4 2019 Feb 14, 2020	BUY	$3.19 - $7.56 $6,431 - $15,240	2,016 Added 28.88%	8,996 $65,000
Q3 2019 Nov 14, 2019	SELL	$4.37 - $9.91 $39,815 - $90,290	-9,111 Reduced 56.62%	6,980 $30,000
Q2 2019 Aug 14, 2019	SELL	$8.77 - $12.49 $87,015 - $123,925	-9,922 Reduced 38.14%	16,091 $158,000
Q1 2019 May 15, 2019	BUY	$10.45 - $13.94 $522 - $697	50 Added 0.19%	26,013 $303,000
Q4 2018 Feb 14, 2019	SELL	$10.43 - $17.39 $261,813 - $436,523	-25,102 Reduced 49.16%	25,963 $311,000
Q3 2018 Dec 21, 2021	BUY	$11.95 - $19.63 $70,600 - $115,974	5,908 Added 13.08%	51,065 $869,000
Q3 2018 Nov 14, 2018	BUY	$11.95 - $19.63 $45,278 - $74,378	3,789 Added 9.16%	45,157 $768,000
Q2 2018 Apr 21, 2020	BUY	$8.75 - $23.27 $61,092 - $162,471	6,982 Added 20.3%	41,368 $706,000
Q2 2018 Aug 14, 2018	BUY	$8.75 - $23.27 $300,877 - $800,162	34,386 New	34,386 $585,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.